Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Rongbei Liu"'
Autor:
Peng Xiao, Xuechun Cai, Zhou Zhang, Ke Guo, Yuehai Ke, Ziwei Hu, Zhangfa Song, Yuening Zhao, Lingya Yao, Manlu Shen, Jingyun Li, Youling Huang, Lingna Ye, Lingjie Huang, Yu Zhang, Rongbei Liu, Mengque Xu, Xutao Xu, Yuan Zhao, Qian Cao
Publikováno v:
Advanced Science, Vol 11, Iss 12, Pp n/a-n/a (2024)
Abstract Most patients with inflammatory bowel disease (IBD) develop anemia, which is attributed to the dysregulation of iron metabolism. Reciprocally, impaired iron homeostasis also aggravates inflammation. How this iron‐mediated, pathogenic anemi
Externí odkaz:
https://doaj.org/article/003b80915b1d47c790f4a3b20aedd369
Autor:
Jing Qi, Guangcong Ruan, Yi Ping, Zhifeng Xiao, Kaijun Liu, Yi Cheng, Rongbei Liu, Bingqiang Zhang, Min Zhi, Junrong Chen, Fang Xiao, Tingting Zhao, Jiaxing Li, Zhou Zhang, Yuxin Zou, Qian Cao, Yongjian Nian, Yanling Wei
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 16 (2023)
Background: The ulcerative colitis (UC) Mayo endoscopy score is a useful tool for evaluating the severity of UC in patients in clinical practice. Objectives: We aimed to develop and validate a deep learning-based approach to automatically predict the
Externí odkaz:
https://doaj.org/article/d341906ab1d74b22b51f319239af653c
Autor:
Guangcong Ruan, Jing Qi, Yi Cheng, Rongbei Liu, Bingqiang Zhang, Min Zhi, Junrong Chen, Fang Xiao, Xiaochun Shen, Ling Fan, Qin Li, Ning Li, Zhujing Qiu, Zhifeng Xiao, Fenghua Xu, Linling Lv, Minjia Chen, Senhong Ying, Lu Chen, Yuting Tian, Guanhu Li, Zhou Zhang, Mi He, Liang Qiao, Zhu Zhang, Dongfeng Chen, Qian Cao, Yongjian Nian, Yanling Wei
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
Background and AimThe identification of ulcerative colitis (UC) and Crohn's disease (CD) is a key element interfering with therapeutic response, but it is often difficult for less experienced endoscopists to identify UC and CD. Therefore, we aimed to
Externí odkaz:
https://doaj.org/article/fcd3eec67f494d64903e45a895b95b0d
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Background and Aims: Ustekinumab (UST) was approved in China for treating moderate-to-severe Crohn’s disease (CD) in 2020. We aimed to identify the reasons and possible contributing factors for UST preference in Chinese patients with CD.Methods: We
Externí odkaz:
https://doaj.org/article/e2a228815b4e48f8bbc0dae0ec89d22a
Autor:
Tingting Su, Rongbei Liu, Allen Lee, Yanqin Long, Lijun Du, Sanchuan Lai, Xueqin Chen, Lan Wang, Jianmin Si, Chung Owyang, Shujie Chen
Publikováno v:
Gastroenterology Research and Practice, Vol 2018 (2018)
Alterations in gut microbiota are postulated to be an etiologic factor in the pathogenesis of irritable bowel syndrome (IBS). To determine whether IBS patients in China exhibited differences in their gut microbial composition, fecal samples were coll
Externí odkaz:
https://doaj.org/article/fdeab9ac99a743beb0a585c7dca4cccf
Autor:
Rongbei Liu, Zhilun Li, Lingna Ye, Jing Hu, Jian Tang, Baili Chen, Xiuli Chen, Bei Tan, Yubei Gu, Chen Xie, Chunhui Ouyang, Xiaomei Song, Fan Li, Yanyun Fan, Haixia Ren, Liangru Zhu, Min Chen, Wenyu Jiang, Qian Cao
Publikováno v:
Inflammatory Bowel Diseases.
BackgroundUstekinumab (UST) was approved in China for moderate-to-severe Crohn’s disease (CD) in 2020. The prevalence rates of tuberculosis and hepatitis B virus (HBV) infection are high in China, and no guideline clearly states that tuberculosis c
Autor:
Yu Zhang, Chaohui Wang, Wu lexi, Chenhao Bai, Kaituo Huang, Lingya Yao, Zhou Zhang, Lingna Ye, Rongbei Liu, Xiaolong Ge, Mengque Xu, Peng Xiao, Yuan Zhao, Qian Cao
Background & Aims: Inflammatory bowel disease (IBD) is becoming more and more popular in the whole wide world. Intestinal epithelial barrier dysfunction is an important step to IBD while the mechanisms are not fully understood. This study aimed to cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ebd9b3f0e3f10a9f687c9b60cf979668
https://doi.org/10.21203/rs.3.rs-2291247/v1
https://doi.org/10.21203/rs.3.rs-2291247/v1
Background: The potential role of EBV infection in ulcerative colitis (UC) patients has not been fully elucidated yet, therefore we aimed to study it further. Methods: 59 biopsy stecimens and 20 surgical specimens of ulcerative colitis were included
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::461c0f8c9f45740a1371a037f55224d5
https://doi.org/10.21203/rs.3.rs-1937368/v1
https://doi.org/10.21203/rs.3.rs-1937368/v1
Publikováno v:
American Journal of Gastroenterology. 117:e562-e562
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 12 (2021)
Frontiers in Pharmacology, Vol 12 (2021)
Background and Aims: Ustekinumab (UST) was approved in China for treating moderate-to-severe Crohn’s disease (CD) in 2020. We aimed to identify the reasons and possible contributing factors for UST preference in Chinese patients with CD.Methods: We